By Bhanvi Satija and Khushi Mandowara (Reuters) – AbbVie’s decision to buy Cerevel Therapeutics before key data on the drug…
Governments spying on Apple, Google users through push notifications -US senator
By Raphael Satter WASHINGTON (Reuters) -Unidentified governments are surveilling smartphone users via their apps’ push notifications, a U.S. senator warned…
Russia’s Putin, Saudi crown prince discuss further OPEC+ cooperation in whirlwind visit
By Aziz El Yaakoubi and Vladimir Soldatkin RIYADH (Reuters) – Russian President Vladimir Putin and Saudi Crown Prince Mohammed bin…
US FTC tries again to stop Microsoft’s already-closed deal for Activision
By Diane Bartz WASHINGTON (Reuters) -U.S. antitrust enforcers argued on Wednesday that a federal judge got it wrong when she…
Delta leans on international travel boom to predict strong start to 2024
By Shivansh Tiwary (Reuters) -Delta Air Lines top executives on Wednesday signaled robust international travel demand going into 2024 as…
ByteDance offers investors share buyback, valued at $268 billion-sources
By Kane Wu and Josh Ye HONG KONG (Reuters) – TikTok owner ByteDance is offering to buy back around $5…
Elon Musk’s AI firm xAI files to raise up to $1 billion in equity offering
(Reuters) -Elon Musk’s artificial intelligence startup xAI has filed with the U.S. securities regulator to raise up to $1 billion…
US crypto industry lobby spending on track for new record in 2023
By Hannah Lang WASHINGTON (Reuters) – The cryptocurrency industry was on track to hit a new record for federal lobbying…
CVS sees upbeat 2024 revenue, plans to simplify drug pricing process
By Leroy Leo and Mariam Sunny (Reuters) -CVS Health on Tuesday forecast 2024 revenue above market estimates and said it…
Johnson & Johnson forecasts as much as 6% sales growth in 2024
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its…